{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:22:51Z","timestamp":1789384971232,"version":"build-2803163510"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/inf.0000000000000331","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T14:33:16Z","timestamp":1394548396000},"page":"953-958","source":"Crossref","is-referenced-by-count":16,"title":["Incidence, Spectrum and Outcome of Immune Reconstitution Syndrome in HIV-infected Children after Initiation of Antiretroviral Therapy"],"prefix":"10.1097","volume":"33","author":[{"given":"Despoina","family":"Gkentzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Tebruegge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Tudor-Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermione","family":"Lyall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Sharland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Doerholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210202","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1086\/521167","article-title":"Collaborative HIV Paediatric Study (CHIPS); National Study of HIV in Pregnancy and Childhood (NSHPC). Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care.","volume":"45","author":"Judd","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R2-16-20210202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jama.296.3.292","article-title":"Incidence of opportunistic and other infections in HIV-infected children in the HAART era.","volume":"296","author":"Gona","year":"2006","journal-title":"JAMA"},{"key":"R3-16-20210202","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/sti.75.4.218","article-title":"Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy.","volume":"75","author":"Kaufmann","year":"1999","journal-title":"Sex Transm Infect"},{"key":"R5-16-20210202","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e3181594c8c","article-title":"Immune reconstitution inflammatory syndrome: risk factors and treatment implications.","volume":"46","author":"Manabe","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-16-20210202","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/135965350501000303","article-title":"Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis.","volume":"10","author":"Michailidis","year":"2005","journal-title":"Antivir Ther"},{"key":"R7-16-20210202","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/01.aids.0000174450.70874.30","article-title":"French Cryptococcosis Study Group. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France.","volume":"19","author":"Lortholary","year":"2005","journal-title":"AIDS"},{"key":"R9-16-20210202","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/00002030-199814000-00013","article-title":"Opportunistic infections occurring during highly active antiretroviral treatment.","volume":"12","author":"Michelet","year":"1998","journal-title":"AIDS"},{"key":"R10-16-20210202","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/499356","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.","volume":"42","author":"Ratnam","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R11-16-20210202","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7326\/0003-4819-157-5-201209040-00004","article-title":"The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.","volume":"157","author":"Naidoo","year":"2012","journal-title":"Ann Intern Med"},{"key":"R13-16-20210202","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jac\/dki444","article-title":"Immune reconstitution inflammatory syndrome: more answers, more questions.","volume":"57","author":"Shelburne","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R14-16-20210202","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jaci.2004.01.768","article-title":"Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.","volume":"113","author":"Tangsinmankong","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R15-16-20210202","first-page":"417","article-title":"Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children.","volume":"11","author":"Zampoli","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"R16-16-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.inf.0000195618.55453.9a","article-title":"Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children.","volume":"25","author":"Puthanakit","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R17-16-20210202","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/433177","article-title":"Immune reconstitution syndrome due to bacillus Calmette-Guerin after initiation of antiretroviral therapy in children with HIV infection.","volume":"41","author":"Puthanakit","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R18-16-20210202","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/01.inf.0000225786.00940.37","article-title":"Immune reconstitution syndrome from nontuberculous mycobacterial infection after initiation of antiretroviral therapy in children with HIV infection.","volume":"25","author":"Puthanakit","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R20-16-20210202","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/QAD.0b013e32833b260a","article-title":"The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children.","volume":"24","author":"Orikiiriza","year":"2010","journal-title":"AIDS"},{"key":"R21-16-20210202","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.327.7422.1019","article-title":"National Study of HIV in Pregnancy and Childhood Collaborative HIV Paediatric Study. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland.","volume":"327","author":"Gibb","year":"2003","journal-title":"BMJ"},{"key":"R24-16-20210202","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","article-title":"Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study.","volume":"22","author":"Murdoch","year":"2008","journal-title":"AIDS"},{"key":"R25-16-20210202","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/INF.0b013e31829ee893","article-title":"LEGACY Consortium. Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in children.","volume":"32","author":"Nesheim","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R26-16-20210202","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jama.2012.9046","article-title":"HIV in persons born outside the United States, 2007-2010.","volume":"308","author":"Prosser","year":"2012","journal-title":"JAMA"},{"key":"R27-16-20210202","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jpedsurg.2006.10.059","article-title":"Adverse reactions to the Bacillus Calmette-Guerin vaccine in HIV-positive infants.","volume":"42","author":"Alexander","year":"2007","journal-title":"J Pediatr Surg"},{"key":"R28-16-20210202","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.inf.0000164769.22033.2c","article-title":"Serious adverse events associated with bacille Calmette-Guerin vaccine in Canada.","volume":"24","author":"Deeks","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R29-16-20210202","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.inf.0000126593.21006.ac","article-title":"Resistant Mycobacterium bovis Bacillus Calmette-Guerin disease: implications for management of Bacillus Calmette-Guerin disease in human immunodeficiency virus-infected children.","volume":"23","author":"Hesseling","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R30-16-20210202","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.01302-08","article-title":"Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.","volume":"53","author":"Ritz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R31-16-20210202","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/425742","article-title":"Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy.","volume":"39","author":"Breton","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R33-16-20210202","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","article-title":"Integration of antiretroviral therapy with tuberculosis treatment.","volume":"365","author":"Abdool Karim","year":"2011","journal-title":"N Engl J Med"},{"key":"R34-16-20210202","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/14787210.4.3.469","article-title":"Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome.","volume":"4","author":"Lesho","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R35-16-20210202","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome.","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T03:13:22Z","timestamp":1689045202000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201409000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000331","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}